Cargando…
Recent progress in the development of anti-malarial quinolones
Available anti-malarial tools have over the ten-year period prior to 2012 dramatically reduced the number of fatalities due to malaria from one million to less than six-hundred and thirty thousand. Although fewer people now die from malaria, emerging resistance to the first-line anti-malarial drugs,...
Autores principales: | Beteck, Richard M, Smit, Frans J, Haynes, Richard K, N’Da, David D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162983/ https://www.ncbi.nlm.nih.gov/pubmed/25176157 http://dx.doi.org/10.1186/1475-2875-13-339 |
Ejemplares similares
-
Quinolone: a versatile therapeutic compound class
por: Dube, Phelelisiwe S., et al.
Publicado: (2022) -
Easy-To-Access Quinolone Derivatives Exhibiting Antibacterial and Anti-Parasitic Activities
por: Beteck, Richard M., et al.
Publicado: (2021) -
Recent Progress in Nitro-Promoted Direct Functionalization of Pyridones and Quinolones
por: Hao, Feiyue, et al.
Publicado: (2020) -
Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
por: Lombard, Marli C, et al.
Publicado: (2013) -
New Quinolone-Based Thiosemicarbazones Showing Activity Against Plasmodium falciparum and Mycobacterium tuberculosis
por: Beteck, Richard M., et al.
Publicado: (2019)